Successful treatment using apatinib in intractable brain edema: A case report and literatures review
Author:
Affiliation:
1. Department of Medical Oncology, Cancer Center, The First Hospital, Jilin University, Changchun, China
2. Department of Radiation Oncology, The First Hospital, Jilin University, Changchun, China
Funder
Science and Technology Department of Jilin Province
National Natural Science Foundation of China (NSFC)
Publisher
Informa UK Limited
Subject
Cancer Research,Pharmacology,Oncology,Molecular Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/15384047.2018.1491502
Reference21 articles.
1. Diagnosis and treatment of brain metastases from solid tumors: guidelines from the European Association of Neuro-Oncology (EANO)
2. Tumor-associated edema in brain cancer patients: pathogenesis and management
3. Incidence Proportions of Brain Metastases in Patients Diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System
4. Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma
5. Apatinib in refractory radiation-induced brain edema
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Prognostic Significance of Plasma VEGFA and VEGFR2 in Acute Ischemic Stroke-a Prospective Cohort Study;Molecular Neurobiology;2024-02-01
2. The anti-tumor efficiency of low-dose apatinib-based chemotherapy in pretreated HER2-negative breast cancer with brain metastases;Annals of Medicine;2023-06
3. Apatinib combined with trastuzumab and albumin‑bound paclitaxel for treatment of HER2+ breast cancer with brain metastases resistant to anti‑HER2 TKIs: A case report;Oncology Letters;2022-12-20
4. Apatinib for recurrent/progressive glioblastoma multiforme: A salvage option;Frontiers in Pharmacology;2022-08-17
5. Blood-Brain Barrier Alterations and Edema Formation in Different Brain Mass Lesions;Frontiers in Cellular Neuroscience;2022-07-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3